Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-03

Clinical Trial Results: A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of ciprofloxacin for plague in humans has been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Plague | Phase 2 | Status: COMPLETED | Results posted: 2026-06-03